Loading...
OTCM
WUHN
Market cap4kUSD
May 23, Last price  
0.00USD
Name

M2bio Sciences Inc

Chart & Performance

D1W1MN
No data to show
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-3.41%
Revenues
Net income
CFO

Profile

Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.
IPO date
Apr 01, 1998
Employees
700
Domiciled in
ZA
Incorporated in
US

Valuation

No data to show